Entolimod
N/A
Report date: 2024/01/02 20:03:52
Base Information
Drug NameEntolimod
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[16]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesCleveland Biolabs Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesTivic Health SystemsCoeptis Therapeutics Holdings IncRoswell Park Cancer Institute +[6]
Active IndicationsN/A
Inactive Indications +[16]